Skip to Content

Malachite Innovations Inc - Stock Quote MLCT

Rating as of

Morningstar's Malachite Innovations Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Malachite Innovations Inc's Company Profile

Business Description

Malachite Innovations Inc is dedicated to improving the health and wellness of people and the planet. Its operating subsidiary seeks to advance novel cannabinoid-glycoside compounds created using its proprietary enzymatic bioprocessing technologies to develop safe and effective novel treatments for chronic and debilitating conditions, with an initial focus on inflammatory bowel disease. Its other subsidiary seeks to identify, invest and reposition challenging environmental situations with a focus on technological innovations and eco-friendly solutions deployed in economically challenged communities.

Contact
200 Park Avenue, Suite 400
Cleveland, OH, 44122
T +1 216 304-6556
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2021
Stock Type Slow Growth
Employees 3